Alloy Therapeutics Acquires Spannerwerks
October 23, 2025
Alloy Therapeutics has acquired Seattle-based Spannerwerks, a drug development consulting firm, which will operate as a wholly owned subsidiary and continue serving clients under the Spannerwerks name. The deal expands Alloy's capabilities beyond discovery into preclinical and clinical development, with Spannerwerks CEO Dara Lockert joining Alloy's leadership team.
- Buyers
- Alloy Therapeutics Inc.
- Targets
- Spannerwerks, LLC
- Industry
- Healthcare Services
- Location
- Washington, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.